J&J, Angiotech Reach Accord Over Stent Patents
Johnson & Johnson subsidiary Conor Medsystems has reached a settlement with Angiotech Pharmaceuticals Inc. to resolve litigation regarding drug-eluting stents used in cancer chemotherapy....To view the full article, register now.
Already a subscriber? Click here to view full article